ZIM
FLGT icon

Zacks Investment Management’s Fulgent Genetics FLGT Stock Holding History

Zacks Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,157
Closed -$937K – 622
2021
Q2 		$937K Sell
10,157
-8,993
-47% -$718K 0.02% 374
2021
Q1 		$1.85M Buy
+19,150
New +$1.98M 0.03% 294

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Zacks Investment Management's FLGT Position: Q3 2021 in Review

Zacks Investment Management sold out of Fulgent Genetics (FLGT) in Q3 2021, closing a stake of 10,157 shares — an estimated $937K sold.

Zacks Investment Management first reported a position in FLGT in Q1 2021 and held it in 2 quarters. The position peaked at $1.85M in Q1 2021. 268 funds tracked by Wall St. Rank hold FLGT as of Q3 2021.

  • Zacks Investment Management reported no remaining Fulgent Genetics position as of Q3 2021 after selling out during the quarter.
  • Zacks Investment Management sold 10,157 Fulgent Genetics shares in Q3 2021, an estimated $937K.
  • Zacks Investment Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 2 quarters.
  • Zacks Investment Management's Fulgent Genetics position peaked at $1.85M in Q1 2021.
  • 268 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2021.

Based on Zacks Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.